Status:
COMPLETED
Evaluation of GeneXpert HIV-1 as The Gold Standard Test for HIV-1 Viral Load Count
Lead Sponsor:
Ina-Respond
Conditions:
HIV
Eligibility:
All Genders
18+ years
Brief Summary
This is a cohort study on HIV-1 patients treated in outpatient and inpatient wards of Tangerang District Hospital. The participant will be interviewed and retrieved for their demographics, treatment h...
Detailed Description
Participant candidate will be screened at Tangerang District Hospital's outpatient and inpatient units. The purpose is to get various VL values from participants with various clinical conditions (ligh...
Eligibility Criteria
Inclusion
- HIV positive patient by the HIV Diagnoses Guideline in the Tangerang District Hospital.
- Patient older than 18 years and above.
- Willing and signed the informed consent (ICF).
- Willing to comply with the study procedures.
Exclusion
- Suffered from a disease or having condition that could complicated the blood drawing process or increasing the risk of disease complications.
- Currently imprisoned.
Key Trial Info
Start Date :
January 8 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 15 2018
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT05977010
Start Date
January 8 2018
End Date
January 15 2018
Last Update
August 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
RSU Kabupaten Tangerang
Tangerang, West Java, Indonesia, 15111